Christobel Selecky
CIK: 0001849739
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ImmunityBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jul 1, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct35.1K shares at avg. $2.98$104K - Jul 1, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct124.4K shares at avg. $2.99$372K - Jul 1, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct159.5K shares at avg. $9.02$1.4M - Jun 30, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct1K shares at avg. $9.00$9K - Jun 30, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct700 shares at avg. $2.98$2K - Jun 30, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct300 shares at avg. $2.99$897 - Jun 29, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct32.2K shares at avg. $2.98$96K - Jun 29, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct33.5K shares at avg. $2.99$100K - Jun 29, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct30K shares at avg. $2.84$85K - Jun 29, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct95.7K shares at avg. $9.01$862K - Jun 9, 2026IBRX
ImmunityBio, Inc.
Award(A)DirectStock Option (right to buy)
65.6K shares- - Feb 23, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct25K shares at avg. $10.00$250K - Feb 23, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct25K shares at avg. $2.98$75K - Jan 20, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct25K shares at avg. $2.98$75K - Jan 20, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct25K shares at avg. $7.51$188K - Jan 16, 2026IBRX
ImmunityBio, Inc.
Sale(S)Direct50K shares at avg. $5.00$250K - Jan 16, 2026IBRX
ImmunityBio, Inc.
Exercise(M)Direct50K shares at avg. $2.98$149K - Jun 18, 2025IBRX
ImmunityBio, Inc.
Award(A)DirectStock Option (right to buy)
162.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 35,064 | $2.98 | $104,491 | Direct |
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 124,414 | $2.99 | $371,998 | Direct |
| Jul 1, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 159,478 | $9.02 | $1,439,066 | Direct |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 1,000 | $9.00 | $9,000 | Direct |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 700 | $2.98 | $2,086 | Direct |
| Jun 30, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 300 | $2.99 | $897 | Direct |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 32,173 | $2.98 | $95,876 | Direct |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 33,549 | $2.99 | $100,312 | Direct |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 30,000 | $2.84 | $85,200 | Direct |
| Jun 29, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 95,722 | $9.01 | $862,216 | Direct |
| Jun 9, 2026 | IBRX ImmunityBio, Inc. | Award(A) Stock Option (right to buy) | 65,600 | - | - | Direct |
| Feb 23, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 25,000 | $10.00 | $250,000 | Direct |
| Feb 23, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 25,000 | $2.98 | $74,500 | Direct |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 25,000 | $2.98 | $74,500 | Direct |
| Jan 20, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 25,000 | $7.51 | $187,650 | Direct |
| Jan 16, 2026 | IBRX ImmunityBio, Inc. | Sale(S) | 50,000 | $5.00 | $250,000 | Direct |
| Jan 16, 2026 | IBRX ImmunityBio, Inc. | Exercise(M) | 50,000 | $2.98 | $149,000 | Direct |
| Jun 18, 2025 | IBRX ImmunityBio, Inc. | Award(A) Stock Option (right to buy) | 162,786 | - | - | Direct |
1-18 of 18 transactions
About Selecky Christobel
Selecky Christobel (SEC CIK 0001849739) files insider reports with the SEC as Director of ImmunityBio, Inc. (IBRX).
Signal8 holds 6 ownership filings by Selecky Christobel, all Form 4s, filed between Jun 20, 2025 and Jul 6, 2026. Those filings report 18 transactions, from Jun 18, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Selecky Christobel's filings is in SAN DIEGO, CA.
Recent filings by Selecky Christobel
- Jul 1, 2026: Option exercises of IBRX shares (2 lines, Form 4, code M).
- Jul 1, 2026: Open-market sale of IBRX shares (Form 4, code S).
- Jun 30, 2026: Open-market sale of IBRX shares (Form 4, code S).
- Jun 30, 2026: Option exercises of IBRX shares (2 lines, Form 4, code M).
- Jun 29, 2026: Option exercises of IBRX shares (3 lines, Form 4, code M).
Other insiders filing for ImmunityBio, Inc. (IBRX)
- Simon Barry J., Director
- Cohen Cheryl, Director
- BLASZYK MICHAEL D, Director
- Wendel Bruce, Director
- MAXWELL LINDA, Director
- Clark Wesley, Director